Evidence map›Paper›PMID 20180778›Full record

ArticleThe Biochemical journal2010

The pseudophosphatase MK-STYX interacts with G3BP and decreases stress granule formation.

Shantá D Hinton, Michael P Myers, Vincent R Roggero, Lizabeth A Allison, Nicholas K Tonks

Open access · hybridAbstract read
In one paragraph

Article in The Biochemical journal, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Understanding Pseudophosphatase Function Through Biochemical Interactions.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Pseudophosphatases as Regulators of MAPK Signaling.International journal of molecular sciences · 2021
    Review
  8. The Roles of Pseudophosphatases in Disease.International journal of molecular sciences · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Shantá D HintonCold Spring Harbor Laboratory, NY 11724, USA.
Michael P Myers
Vincent R Roggero
Lizabeth A Allison
Nicholas K Tonks
Cold Spring Harbor Laboratory · USWilliam & Mary · USHampton University · US

Funding

PROTEIN TYROSINE DEPHOSPHORYLATION &SIGNAL TRANSDUCTIONR01CA053840 · NCI · COLD SPRING HARBOR LABORATORY · PI TONKS, NICHOLAS K · 1991 to 2025
$11.8M
Protein Tyrosine Dephosphorylation &signal TransductionR37CA053840 · NCI · COLD SPRING HARBOR LABORATORY · PI TONKS, NICHOLAS K · 2001 to 2008
$5.2M
Howard Hughes Medical Institute 52005868NCI NIH HHS CA53840NCI NIH HHS R01 CA053840NCI NIH HHS R37 CA053840Wellcome Trust
6 · The paper itself

Abstract

MK-STYX [MAPK (mitogen-activated protein kinase) phospho-serine/threonine/tyrosine-binding protein] is a pseudophosphatase member of the dual-specificity phosphatase subfamily of the PTPs (protein tyrosine phosphatases). MK-STYX is catalytically inactive due to the absence of two amino acids from the signature motif that are essential for phosphatase activity. The nucleophilic cysteine residue and the adjacent histidine residue, which are conserved in all active dual-specificity phosphatases, are replaced by serine and phenylalanine residues respectively in MK-STYX. Mutations to introduce histidine and cysteine residues into the active site of MK-STYX generated an active phosphatase. Using MS, we identified G3BP1 [Ras-GAP (GTPase-activating protein) SH3 (Src homology 3) domain-binding protein-1], a regulator of Ras signalling, as a binding partner of MK-STYX. We observed that G3BP1 bound to native MK-STYX; however, binding to the mutant catalytically active form of MK-STYX was dramatically reduced. G3BP1 is also an RNA-binding protein with endoribonuclease activity that is recruited to 'stress granules' after stress stimuli. Stress granules are large subcellular structures that serve as sites of mRNA sorting, in which untranslated mRNAs accumulate. We have shown that expression of MK-STYX inhibited stress granule formation induced either by aresenite or expression of G3BP itself; however, the catalytically active mutant MK-STYX was impaired in its ability to inhibit G3BP-induced stress granule assembly. These results reveal a novel facet of the function of a member of the PTP family, illustrating a role for MK-STYX in regulating the ability of G3BP1 to integrate changes in growth-factor stimulation and environmental stress with the regulation of protein synthesis.

Indexed as

AnimalsCarrier ProteinsCell LineChlorocebus aethiopsCOS CellsCytoplasmic GranulesDNA HelicasesDual-Specificity PhosphatasesHeLa CellsHumansImmunoblottingImmunoprecipitationPoly-ADP-Ribose Binding ProteinsProtein BindingRNA HelicasesRNA Recognition Motif ProteinsCarrier ProteinsDNA HelicasesDual-Specificity PhosphatasesG3BP1 protein, humanPoly-ADP-Ribose Binding ProteinsRNA HelicasesRNA Recognition Motif Proteins

Identifiers

PMID20180778
PMCPMC2873733
OpenAlexW2134029077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.